Health Care & Life Sciences » Biotechnology | Neptune Technologies & Bioressources Inc.

Neptune Technologies & Bioressources Inc. | Mutual Funds

Mutual Funds that own Neptune Technologies & Bioressources Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
2,254,809
2.85%
12,898
1.25%
07/31/2018
Desjardins Quebec Balanced Fund
125,683
0.16%
125,683
0.11%
04/30/2018
Fidelity Nasdaq Composite Index
76,890
0.1%
0
0.01%
07/31/2018
iShares S&P/TSX Small Cap Index ETF
73,167
0.09%
0
0.32%
09/06/2018
23,000
0.03%
23,000
0.39%
06/30/2018
First Asset Morningstar National Bank Quebec Index ETF
22,122
0.03%
22,122
0.16%
07/31/2018
DFA Canadian Small Company Series
22,102
0.03%
0
0.01%
01/31/2018
17,438
0.02%
0
3.35%
03/14/2018
DFA Canadian Vector Equity Fund
7,400
0.01%
7,400
0.01%
12/31/2017
DFA International Vector Equity Portfolio
6,516
0.01%
0
0%
04/30/2018

About Neptune Technologies & Bioressources

View Profile
Address
545, Promenade du Centropolis
Laval Québec H7T 0A3
Canada
Employees -
Website http://www.neptunecorp.com
Updated 07/08/2019
Neptune Technologies & Bioresources, Inc. engages in the development and commercialization specialty ingredients. It offers the MaxSimil a patented ingredient that may enhance the absorption of lipid-based nutraceuticals, and a variety of other marine and seed oils. It operates through the Nutraceutical, Cannabis, and Cardiovascular segments.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.